Abstract:INTRODUCTION . The distinctive nature and composition of biological medicinal products present certain challenges for the detection of microbial contamination, which affects the reliability of sterility control results. The main challenges associated with testing biologicals include changes in the appearance and physical properties of culture media or samples, an increased risk of contamination or false-positive results in direct inoculation tests, filtration issues, etc. When drafting product specification files and analytical method validation reports in dossiers for biologicals, manufacturers need adequate, reproducible, and pharmacopoeia-based sterility testing procedures for specific medicinal products, including live and inactivated, viral and bacterial, single- and multi-component vaccines, bacteriophages and interferons, sera and immunoglobulins. These challenges can be addressed through providing recommendations for developing analytical procedures based on compendial methods of direct inoculation and membrane filtration. AIM . This study aimed to offer key recommendations for the development of sterility testing procedures for biologicals based on pharmacopoeial methods. DISCUSSION . This article presents a retrospective analysis of the results of reviewing regulatory documentation for biological medicinal products submitted to the testing centre of the Scientific Centre for Expert Evaluation of Medicinal Products in 2021–2023. Having considered major issues with the analytical procedures described in the Sterility section of regulatory submissions, the authors offer the following recommendations for addressing these issues. The authors advise against using low-pH Sabouraud culture media to test blood products by direct inoculation. Biologicals containing mercury preservatives should be tested using a thioglycollate medium at two temperature settings. When testing various biologicals, analysts should refrain from plugging vials with cotton gauze. Instead, they should pour culture media into glass vials with rubber stoppers and crimps. Biologicals in large primary packaging (≥10 mL) should be tested by membrane filtration. Membrane filtration tests for biologicals should use solvents and rinsing agents selected in validation studies. It is also recommended to set the maximum volume of a biological medicinal product that can be filtered through a membrane filter. A reduction in the filtration speed is recommended to minimise foaming when testing blood products. CONCLUSION . The recommendations presented in this article can guide the development of sterility testing procedures for inclusion in the relevant section of regulatory submissions for biologicals. Manufacturers, control laboratories, and regulatory authorities may implement these recommendations to harmonise their approach to sterility testing of biologicals.

Biological Reference Materials: Topical Issues of Development and Certification Procedure

Quality Management System in Production of Reference Materials

Reference Materials for the Composition of Antimicrobial Substances

Approaches for the production of reference materials with qualitative properties—The new International Standard ISO 33406

STATUS OF REFERENCE MATERIALS PROGRAMME IN INDIA

Quality Assurance of Medicines: Main Scientific Approaches and Control Methods

Recommendations for the development of sterility testing procedures for biological medicinal products based on pharmacopoeial methods

Production and certification of a freeze-dried reference material for human urinary steroids to ensure quality of longitudinal profiling data

Design and development of topical liposomal formulations in a regulatory perspective

Current and Future Pharmacopoeial Requirements for the Quality of Extemporaneous Medicinal Products: A Review of Regulatory Standards

Development of purity certified reference materials to establish metrological traceability for the measurement of nitroimidazoles in agricultural products

Metrological Support in the Field for the Development of Reference Materials of Isothermal Titration Calorimetry: Prospects

The new ISO Guide 80: Guidance for the in-house preparation of quality control materials (QCMs)

Establishment of measurement traceability for peptide and protein quantification through rigorous purity assessment—a review

Production and certification of BOTS-1: bovine muscle–certified reference material for incurred veterinary drug residues

Development of a certified reference material for the analysis of vitamins in multivitamin tablets

The Use of Reference Materials In the Analysis of Medicinal Plant Raw Materials and Herbal Medicinal Products

From urban dust and marine sediment to Ginkgo biloba and human serum—a top ten list of Standard Reference Materials (SRMs)

Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC)

Long-Term Metabolomics Reference Material

Optimizing Available Tools for Achieving Result Standardization: Value Added by Joint Committee on Traceability in Laboratory Medicine (JCTLM)